{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:31:54Z","timestamp":1793136714189,"version":"4.5.0"},"reference-count":34,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Ischemic complications account for significant patient morbidity following aneurysmal subarachnoid hemorrhage (aSAH). The Prevention and Treatment of Vasospasm with Clazosentan (REACT) study was designed to assess the safety and efficacy of clazosentan, an endothelin receptor antagonist, in preventing clinical deterioration due to delayed cerebral ischemia (DCI) in patients with aSAH.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>REACT was a prospective, multicenter, randomized, double-blind, phase 3 study. Eligible patients had aSAH secured by surgical clipping or endovascular coiling, and had presented with thick and diffuse clot on admission CT scan. Patients were randomized (1:1 ratio) to 15 mg\/hour intravenous clazosentan or placebo within 96 hours of the aSAH for up to 14 days, in addition to standard of care treatment including oral or intravenous nimodipine. The primary efficacy endpoint was the occurrence of clinical deterioration due to DCI up to 14 days after initiation of the study drug. The main secondary endpoint was the occurrence of clinically relevant cerebral infarction at day 16 after study drug initiation. Other secondary endpoints included clinical outcome assessed on the modified Rankin Scale (mRS) and the Glasgow Outcome Scale\u2013Extended (GOSE) at week 12 post-aSAH. Imaging and clinical endpoints were centrally adjudicated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>A total of 409 patients were randomized between February 2019 and May 2022 across 74 international sites. Three patients did not start study treatment and were not included in the analysis set. The occurrence of clinical deterioration due to DCI was 15.8% (32\/202 patients) in the clazosentan group and 17.2% (35\/204 patients) in the placebo group, and the difference was not statistically significant (relative risk reduction [RRR] 7.2%, 95% CI \u201342.6% to 39.6%, p = 0.734). A nonsignificant RRR of 34.1% (95% CI \u201321.3% to 64.2%, p = 0.177) was observed in clinically relevant cerebral infarcts treated with clazosentan (7.4%, 15\/202) versus placebo (11.3%, 23\/204). Rescue therapy was less frequently needed for patients treated with clazosentan compared to placebo (10.4%, 21\/202 vs 18.1%, 37\/204; RRR 42.6%, 95% CI 5.4%\u201365.2%). A nonsignificant relative risk increase of 25.4% (95% CI \u201310.7% to 76.0%, p = 0.198) was reported in the risk of poor GOSE and mRS scores with clazosentan (24.8%, 50\/202) versus placebo (20.1%, 41\/204) at week 12 post-aSAH. Treatment-emergent adverse events were similar to those reported previously.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Clazosentan administered for up to 14 days at 15 mg\/hour had no significant effect on the occurrence of clinical deterioration due to DCI.<\/jats:p>\n<jats:p>Clinical trial registration no.: NCT03585270 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:ext-link>)<\/jats:p>\n<jats:p>EU clinical trial registration no.: 2018-000241-39 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrialsregister.eu\">clinicaltrialsregister.eu<\/jats:ext-link>)<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.4.jns232191","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T01:30:40Z","timestamp":1723253440000},"page":"1-12","source":"Crossref","is-referenced-by-count":46,"title":["REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage"],"prefix":"10.3171","author":[{"given":"Stephan A.","family":"Mayer","sequence":"first","affiliation":[{"name":"Neurocritical Care and Emergency Neurological Services, Westchester Medical Center Health Network, Valhalla, New York;"},{"name":"Department of Neurology and Neurosurgery, New York Medical College, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bruder","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care, CHU Timone, APHM, Aix-Marseille University, Marseille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citerio","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defreyne","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology and Neuroradiology, Ghent University, Ghent, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Dubois","sequence":"additional","affiliation":[{"name":"Biometry, Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Neuroradiology, Massachusetts General Hospital, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Higashida","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Neurointerventional Radiology, University of California, San Francisco Medical Center, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Marr","sequence":"additional","affiliation":[{"name":"Global Clinical Development, Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh N.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurosurgery, and Radiology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Roux","sequence":"additional","affiliation":[{"name":"Global Clinical Development, Idorsia Pharmaceuticals Ltd., Allschwil, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Smr\u010dka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Brno, Czechia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Torn\u00e9","family":"Torn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Clinic of Barcelona, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Fran\u00e7ois","family":"Aldrich","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Maryland, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"_","family":"_","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wittebole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Defreyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Creteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Ledoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Darsaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwynedd","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Brad\u00e1\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Smrcka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svatopluk","family":"\u0158eh\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Hrbac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Priban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels Halfeld","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Ronkainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justiina","family":"Huhtakangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Chabanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ritzenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Degos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Costalat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Calviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eti\u00e9nne","family":"Gayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Bele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas W.","family":"Unterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wostrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Brandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Ey\u00fcpoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Konczalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Dammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Berlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Petridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Lajgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Barz\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"B\u00fcki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal","family":"Shoshann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagi","family":"Harnof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Munari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselmo","family":"Caricato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"S\u0142oniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Kunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"\u015aniegocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Jask\u00f3lski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Juszkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Fernandez","family":"Alen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat Arikan","family":"Abello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu Gabarros","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon Torn\u00e9","family":"Torn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Morera","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Dominguez","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n","family":"Romero-Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ljungqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Aneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Eneling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ogilvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bambakidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reavey-Cantwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bappaditya","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Ortiz","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoom","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Amin-Hanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir","family":"Erkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem","family":"Shoirah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Aldrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Froehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cockroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Romit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"7","key":"b1","series-title":"Lancet Neurol","first-page":"635","article-title":"Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis","volume":"8","author":"Nieuwkamp DJ","year":"2009","unstructured":"Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635\u2013642."},{"issue":"7","key":"b2","series-title":"Stroke","first-page":"e314","article-title":"2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"54","author":"Hoh BL","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S,  2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2023;54(7):e314\u2013e370."},{"issue":"8","key":"b3","series-title":"Stroke","first-page":"e519","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi T","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519\u2013e536."},{"issue":"13","key":"b4","series-title":"Neurology","first-page":"e1819","article-title":"Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage","volume":"95","author":"Roquer J","year":"2020","unstructured":"Roquer J, Cuadrado-Godia E, Guimaraens L,  Short- and long-term outcome of patients with aneurysmal subarachnoid hemorrhage. Neurology. 2020;95(13):e1819\u2013e1829."},{"key":"b5","series-title":"Handb Clin Neurol","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-444-63600-3.00012-X","article-title":"Management of aneurysmal subarachnoid hemorrhage","volume":"140","author":"Etminan N","year":"2017","unstructured":"Etminan N, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol. 2017;140:195\u2013228."},{"issue":"3","key":"b6","series-title":"Neurosurg Focus","first-page":"E2","article-title":"Time trends in the risk of delayed cerebral ischemia after subarachnoid hemorrhage: a meta-analysis of randomized controlled trials","volume":"52","author":"Rigante L","year":"2022","unstructured":"Rigante L, van Lieshout JH, Vergouwen MDI,  Time trends in the risk of delayed cerebral ischemia after subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. Neurosurg Focus. 2022;52(3):E2."},{"issue":"Pt 1","key":"b7","series-title":"Acta Neurochir Suppl","first-page":"5","article-title":"A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture","volume":"110","author":"Dorsch N","year":"2011","unstructured":"Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl. 2011;110(Pt 1):5-6."},{"key":"b8","series-title":"World Neurosurg","first-page":"e527","article-title":"Risk factors for mild cognitive impairment in patients with aneurysmal subarachnoid hemorrhage treated with endovascular coiling","volume":"119","author":"Shen Y","year":"2018","unstructured":"Shen Y, Dong Z, Pan P, Shi H, Song Y. Risk factors for mild cognitive impairment in patients with aneurysmal subarachnoid hemorrhage treated with endovascular coiling. World Neurosurg. 2018;119:e527\u2013e533."},{"issue":"5","key":"b9","series-title":"World Neurosurg","first-page":"e599","article-title":"Delayed cerebral ischemia predicts neurocognitive impairment following aneurysmal subarachnoid hemorrhage","volume":"82","author":"Stienen MN","year":"2014","unstructured":"Stienen MN, Smoll NR, Weisshaupt R,  Delayed cerebral ischemia predicts neurocognitive impairment following aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82(5):e599\u2013e605."},{"issue":"6","key":"b10","series-title":"Stroke","first-page":"1963","article-title":"Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?","volume":"40","author":"Frontera JA","year":"2009","unstructured":"Frontera JA, Fernandez A, Schmidt JM,  Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke. 2009;40(6):1963\u20131968."},{"issue":"6","key":"b11","series-title":"Neurosurgery","first-page":"1043","article-title":"Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage","volume":"65","author":"Springer MV","year":"2009","unstructured":"Springer MV, Schmidt JM, Wartenberg KE, Frontera JA, Badjatia N, Mayer SA. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65(6):1043\u20131051."},{"issue":"3","key":"b12","series-title":"PLoS One","first-page":"e0247942","article-title":"Long-term outcome in patients with aneurysmal subarachnoid hemorrhage requiring mechanical ventilation","volume":"16","author":"Chalard K","year":"2021","unstructured":"Chalard K, Szabo V, Pavillard F,  Long-term outcome in patients with aneurysmal subarachnoid hemorrhage requiring mechanical ventilation. PLoS One. 2021;16(3):e0247942."},{"issue":"15","key":"b13","series-title":"J Am Heart Assoc","first-page":"e021845","article-title":"Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review","volume":"10","author":"Dodd WS","year":"2021","unstructured":"Dodd WS, Laurent D, Dumont AS,  Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc. 2021;10(15):e021845."},{"key":"b14","series-title":"World Neurosurg","first-page":"513","article-title":"A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"126","author":"Li K","year":"2019","unstructured":"Li K, Barras CD, Chandra RV,  A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513\u2013527."},{"issue":"2","key":"b15","series-title":"Cerebrovasc Dis","first-page":"93","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner T","year":"2013","unstructured":"Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93\u2013112."},{"issue":"11","key":"b16","series-title":"J Cereb Blood Flow Metab","first-page":"1761","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen MD","year":"2008","unstructured":"Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761\u20131770."},{"issue":"6163","key":"b17","series-title":"Nature","first-page":"411","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa M","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S,  A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):411\u2013415."},{"issue":"3","key":"b18","series-title":"J Pharmacol Exp Ther","first-page":"1110","article-title":"Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm","volume":"283","author":"Roux S","year":"1997","unstructured":"Roux S, Breu V, Giller T,  Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther. 1997;283(3):1110\u20131118."},{"issue":"2","key":"b19","series-title":"Pharmacol Rev","first-page":"357","article-title":"Endothelin","volume":"68","author":"Davenport AP","year":"2016","unstructured":"Davenport AP, Hyndman KA, Dhaun N,  Endothelin. Pharmacol Rev. 2016;68(2):357\u2013418."},{"issue":"Suppl 3","key":"b20","series-title":"J Cardiovasc Pharmacol","first-page":"S326","article-title":"Autoradiographic study of endothelin receptors in human cerebral arteries","volume":"26","author":"Pierre LN","year":"1995","unstructured":"Pierre LN, Davenport AP. Autoradiographic study of endothelin receptors in human cerebral arteries. J Cardiovasc Pharmacol. 1995;26(Suppl 3):S326\u2013S328."},{"issue":"1","key":"b21","series-title":"Neurocrit Care","first-page":"19","article-title":"Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia","volume":"15","author":"Thampatty BP","year":"2011","unstructured":"Thampatty BP, Sherwood PR, Gallek MJ,  Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: associations with vasospasm and delayed cerebral ischemia. Neurocrit Care. 2011;15(1):19\u201327."},{"issue":"1","key":"b22","series-title":"J Neurosurg","first-page":"9","article-title":"Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study","volume":"103","author":"Vajkoczy P","year":"2005","unstructured":"Vajkoczy P, Meyer B, Weidauer S,  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103(1):9\u201317."},{"issue":"11","key":"b23","series-title":"Stroke","first-page":"3015","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald RL","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S,  Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015\u20133021."},{"issue":"1-2","key":"b24","series-title":"Cerebrovasc Dis","first-page":"59","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura M","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis. 2017;44(1-2):59\u201367."},{"issue":"6","key":"b25","series-title":"J Neurosurg","first-page":"1707","article-title":"Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients","volume":"137","author":"Endo H","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N,  Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137(6):1707\u20131717."},{"issue":"1","key":"b26","series-title":"BMC Neurol","first-page":"492","article-title":"The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"22","author":"Bruder N","year":"2022","unstructured":"Bruder N, Higashida R, Santin-Janin H,  The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. BMC Neurol. 2022;22(1):492."},{"issue":"6","key":"b27","series-title":"Stroke","first-page":"1463","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald RL","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E,  Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463\u20131469."},{"issue":"10","key":"b28","series-title":"Stroke","first-page":"2738","article-title":"Thick and diffuse subarachnoid blood as a treatment effect modifier of clazosentan after subarachnoid hemorrhage","volume":"50","author":"Mayer SA","year":"2019","unstructured":"Mayer SA, Aldrich EF, Bruder N,  Thick and diffuse subarachnoid blood as a treatment effect modifier of clazosentan after subarachnoid hemorrhage. Stroke. 2019;50(10):2738\u20132744."},{"issue":"7","key":"b29","series-title":"Lancet Neurol","first-page":"618","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald RL","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E,  Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u2013625."},{"issue":"12","key":"b30","series-title":"Neuroradiology","first-page":"813","article-title":"Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"51","author":"Dankbaar JW","year":"2009","unstructured":"Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJ, Rinkel GJ. Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2009;51(12):813\u2013819."},{"issue":"6","key":"b31","series-title":"J Cereb Blood Flow Metab","first-page":"1443","article-title":"Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"31","author":"Etminan N","year":"2011","unstructured":"Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL. Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2011;31(6):1443\u20131451."},{"issue":"16","key":"b32","series-title":"J Clin Med","first-page":"4642","article-title":"Vasospasm-related death after aneurysmal subarachnoid hemorrhage: a retrospective case-control study","volume":"11","author":"Khanafer A","year":"2022","unstructured":"Khanafer A, Bhogal P, Hellstern V,  Vasospasm-related death after aneurysmal subarachnoid hemorrhage: a retrospective case-control study. J Clin Med. 2022;11(16):4642."},{"issue":"3","key":"b33","series-title":"Neurocrit Care","first-page":"534","article-title":"A systematic review of outcome measures employed in aneurysmal subarachnoid hemorrhage (aSAH) clinical research","volume":"30","author":"Andersen CR","year":"2019","unstructured":"Andersen CR, Fitzgerald E, Delaney A, Finfer S. A systematic review of outcome measures employed in aneurysmal subarachnoid hemorrhage (aSAH) clinical research. Neurocrit Care. 2019;30(3):534\u2013541."},{"issue":"2","key":"b34","series-title":"Acta Neurol Scand","first-page":"76","article-title":"Outcome 1 year after aneurysmal subarachnoid hemorrhage: relation between cognitive performance and neuroimaging","volume":"112","author":"Egge A","year":"2005","unstructured":"Egge A, Waterloo K, Sj\u00f8holm H,  Outcome 1 year after aneurysmal subarachnoid hemorrhage: relation between cognitive performance and neuroimaging. Acta Neurol Scand. 2005;112(2):76\u201380."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS232191\/article-10.3171-2024.4.JNS232191.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS232191\/article-10.3171-2024.4.JNS232191.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS232191\/article-10.3171-2024.4.JNS232191.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T01:25:22Z","timestamp":1735349122000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/aop\/article-10.3171-2024.4.JNS232191\/article-10.3171-2024.4.JNS232191.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3171\/2024.4.jns232191","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}